Literature DB >> 17098212

Redox in redux: Emergent roles for glutathione S-transferase P (GSTP) in regulation of cell signaling and S-glutathionylation.

Kenneth D Tew1.   

Abstract

Glutathione (GSH) provides a major source of thiol homeostasis critical to the maintenance of a reduced cellular environment that is conducive to cell survival. Mammals have accumulated a significant cadre of sulfur containing proteins, the interactive significance of which has become clear in recent times. Glutathione transferases (GST) are prevalent in eukaryotes and have been ascribed catalytic functions that involve detoxification of electrophiles through thioether bond formation with the cysteine thiol of GSH. The neutralizing impact of these reactions on products of reactive oxygen has contributed to the significant evolutionary conservation and adaptive functional redundancy of the multifaceted GSH system. Amongst the GSTs, GSTP has been implicated in tumorigenesis and in anticancer drug resistance. Emerging studies indicate that GSTP has ligand binding properties and contributes in the regulation of signaling kinases through direct protein:protein interactions. Furthermore, S-glutathionylation is a post-translational modification of low pK(a) cysteine residues in target proteins. The forward rate of the S-glutathionylation reaction can be influenced by GSTP, whereas the reverse rate is affected by a number of redox sensitive proteins including glutaredoxin, thioredoxin and sulfiredoxin. The functional importance of these reactions in governing how cells respond to oxidative or nitrosative stress exemplifies the broad importance of GSH/GST homeostasis in conditions such as cancer, ageing and neurodegenerative diseases. GSTP has also provided a platform for therapeutic drug development where some agents have completed preclinical testing and are in clinical trial for the management of cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17098212     DOI: 10.1016/j.bcp.2006.09.027

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  37 in total

1.  Cellular resistance to a nitric oxide releasing glutathione S-transferase P-activated prodrug, PABA/NO.

Authors:  Steven Hutchens; Yefim Manevich; Lin He; Kenneth D Tew; Danyelle M Townsend
Journal:  Invest New Drugs       Date:  2010-03-16       Impact factor: 3.850

Review 2.  Redox platforms in cancer drug discovery and development.

Authors:  Kenneth D Tew; Danyelle M Townsend
Journal:  Curr Opin Chem Biol       Date:  2010-11-11       Impact factor: 8.822

3.  Effects of gene polymorphisms on the risk of severe hyponatremia during DCF chemotherapy for patients with esophageal squamous cell carcinoma.

Authors:  Yasuhiro Arakawa; Yoshihiro Shirai; Kazumi Hayashi; Yujiro Tanaka; Akira Matsumoto; Katsunori Nishikawa; Shingo Yano
Journal:  Oncol Lett       Date:  2018-07-31       Impact factor: 2.967

4.  Protein cysteine sulfinic acid reductase (sulfiredoxin) as a regulator of cell proliferation and drug response.

Authors:  K Lei; D M Townsend; K D Tew
Journal:  Oncogene       Date:  2008-05-05       Impact factor: 9.867

5.  Nitrosative stress-induced s-glutathionylation of protein disulfide isomerase leads to activation of the unfolded protein response.

Authors:  Danyelle M Townsend; Yefim Manevich; Lin He; Ying Xiong; Robert R Bowers; Steven Hutchens; Kenneth D Tew
Journal:  Cancer Res       Date:  2009-09-22       Impact factor: 12.701

6.  Novel role for glutathione S-transferase pi. Regulator of protein S-Glutathionylation following oxidative and nitrosative stress.

Authors:  Danyelle M Townsend; Yefim Manevich; Lin He; Steven Hutchens; Christopher J Pazoles; Kenneth D Tew
Journal:  J Biol Chem       Date:  2008-11-06       Impact factor: 5.157

7.  Pharmacology of a mimetic of glutathione disulfide, NOV-002.

Authors:  Danyelle M Townsend; Kenneth D Tew
Journal:  Biomed Pharmacother       Date:  2008-09-17       Impact factor: 6.529

8.  Aryl bis(diazeniumdiolates): potent inducers of S-glutathionylation of cellular proteins and their in vitro antiproliferative activities.

Authors:  Daniela Andrei; Anna E Maciag; Harinath Chakrapani; Michael L Citro; Larry K Keefer; Joseph E Saavedra
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

Review 9.  Redox regulation in cancer: a double-edged sword with therapeutic potential.

Authors:  Asha Acharya; Ila Das; Des Chandhok; Tapas Saha
Journal:  Oxid Med Cell Longev       Date:  2010 Jan-Feb       Impact factor: 6.543

10.  Minimally perturbing a gene regulatory network to avoid a disease phenotype: the glioma network as a test case.

Authors:  Guy Karlebach; Ron Shamir
Journal:  BMC Syst Biol       Date:  2010-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.